Yan M

No ORCID on file · 9 papers in corpus
2026
Genes
2025
Nutrients ·doi:10.3390/nu17020356

ObjectiveTo investigate the relationship between protein-rich foods, various nutritional supplements, and age of natural menopause and its symptoms.MethodsThis study was a large-scale cross-sectional survey. A multi-stage stratified random …

2025
Frontiers in medicine ·doi:10.3389/fmed.2025.1604790

BackgroundThis phase 2 trial comprised dose exploration (stage 1) and dose confirmation stages (stage 2) to determine the safety and efficacy of HSK21542 in patients undergoing laparoscopic abdominal surgery.MethodsIn stage 1, patients were…

2025
International journal of medical sciences ·doi:10.7150/ijms.114851

Background: Tuberculosis is a communicable disease that is a major cause of ill health and one of the leading causes of death worldwide. Latent tuberculosis infection (LTBI) widely exists in people all over the world, especially in patients…

2025
Frontiers in endocrinology ·doi:10.3389/fendo.2025.1573206

BackgroundAdvanced maternal age (AMA) is associated with increased infertility and poor outcomes of in vitro fertilization (IVF), with limited effective treatments available. The traditional Chinese medicine (TCM) formula Qiziyusi decoction…

2024
NPJ biofilms and microbiomes ·doi:10.1038/s41522-024-00577-7

Gynecologic cancers develop from the female reproductive organs. Microbial dysbiosis in the gut and oral cavity can communicate with each other through various ways, leading to mucosal destruction, inflammatory response, genomic instability…

review 2023
Medicine ·doi:10.1097/md.0000000000036279

RATIONALE: Pulmonary embolism (PE) is a common cause of cardiovascular death whose major acquired risk factors include postoperative states, pregnancy, malignancy, and age. We report a case of PE that occurred after diagnostic curettage for…

2019
Molecular genetics & genomic medicine ·doi:10.1002/mgg3.516

BackgroundDisordered inflammation and immune response is an acknowledged risk factor for cervical cancer development. Interleukin-1 receptor type 2 (IL1R2) is a decoy receptor for IL-1 cytokines and involved in host inflammatory and immune …

letter 2007
Pathology ·doi:10.1080/00313020701444556